Related Experiment Video
Updated: Aug 13, 2025

Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay
Published on: June 9, 2017
Pan-cancer antagonistic inhibition pattern of ATM-driven G2/M checkpoint pathway vs other DNA repair pathways
Marianna A Zolotovskaia1, Alexander A Modestov2, Maria V Suntsova3
1Laboratory for Translational Genomic Bioinformatics, Moscow Institute of Physics and Technology, Dolgoprudny, Moscow Region 141701, Russia; Omicsway Corp., Walnut, CA, 91789, USA.
Abstract:
DNA repair mechanisms keep genome integrity and limit tumor-associated alterations and heterogeneity, but on the other hand they promote tumor survival after radiation and genotoxic chemotherapies. We screened pathway activation levels of 38 DNA repair pathways in nine human cancer types (gliomas, breast, colorectal, lung, thyroid, cervical, kidney, gastric, and pancreatic cancers). We took RNAseq profiles of the experimental 51 normal and 408 tumor samples, and from The Cancer Genome Atlas and Clinical Proteomic Tumor Analysis Consortium databases - of 500/407 normal and 5752/646 tumor samples, and also 573 normal and 984 tumor proteomic profiles from Proteomic Data Commons portal. For all the samplings we observed a congruent trend that all cancer types showed inhibition of G2/M arrest checkpoint pathway compared to the normal samples, and relatively low activities of p53-mediated pathways. In contrast, other DNA repair pathways were upregulated in most of the cancer types. The G2/M checkpoint pathway was statistically significantly downregulated compared to the other DNA repair pathways, and this inhibition was strongly impacted by antagonistic regulation of (i) promitotic genes CCNB and CDK1, and (ii) GADD45 genes promoting G2/M arrest. At the DNA level, we found that ATM, TP53, and CDKN1A genes accumulated loss of function mutations, and cyclin B complex genes - transforming mutations. These findings suggest importance of activation for most of DNA repair pathways in cancer progression, with remarkable exceptions of G2/M checkpoint and p53-related pathways which are downregulated and neutrally activated, respectively.
Insights
Most DNA repair pathways are upregulated in cancers, but G2/M checkpoints and p53 pathways are notably downregulated. This suggests their critical roles in cancer progression and therapeutic resistance.
Area of Science:
- Molecular Biology
- Cancer Genomics
- Biochemistry
Background:
- DNA repair mechanisms are crucial for maintaining genome integrity.
- These pathways can also promote cancer cell survival following genotoxic therapies.
- Understanding DNA repair pathway dysregulation is key to cancer treatment strategies.
Purpose of the Study:
- To investigate the activation status of 38 DNA repair pathways across nine human cancer types.
- To compare DNA repair pathway activity in tumor samples versus normal tissues.
- To identify specific pathways that are consistently altered during cancer development.
Main Methods:
- Analysis of RNA sequencing and proteomic profiles from The Cancer Genome Atlas and Clinical Proteomic Tumor Analysis Consortium databases.
- Screening of pathway activation levels in over 500 normal and 5700 tumor samples.
- Statistical analysis to compare pathway activities between cancer types and normal tissues.
Main Results:
- A congruent trend of G2/M arrest checkpoint pathway inhibition was observed in all analyzed cancer types compared to normal samples.
- p53-mediated pathways showed relatively low activity across most cancer types.
- Most other DNA repair pathways were found to be upregulated in the majority of cancer types.
- The G2/M checkpoint pathway's downregulation was linked to antagonistic regulation of CCNB, CDK1, and GADD45 genes.
- Loss-of-function mutations in ATM, TP53, and CDKN1A, and transforming mutations in cyclin B complex genes were identified.
Conclusions:
- The activation of most DNA repair pathways is important for cancer progression.
- The downregulation of the G2/M checkpoint and p53-related pathways represents a significant exception.
- These findings highlight potential therapeutic targets and biomarkers for cancer treatment.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway
Long-patch Base Excision Repair
Inhibition of Cdk Activity
DNA Damage Can Stall the Cell Cycle
Restarting Stalled Replication Forks

